157 related articles for article (PubMed ID: 24323988)
1. Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.
Hospital MA; Viala K; Dragomir S; Levy V; Cohen-Aubart F; Neil J; Musset L; Choquet S; Leger JM; Leblond V
Haematologica; 2013 Dec; 98(12):e155-7. PubMed ID: 24323988
[No Abstract] [Full Text] [Related]
2. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
Gruson B; Ghomari K; Beaumont M; Garidi R; Just A; Merle P; Merlusca L; Marolleau JP; Royer B
J Peripher Nerv Syst; 2011 Sep; 16(3):180-5. PubMed ID: 22003932
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Souayah N; Noopur R; Tick-Chong PS
Immunopharmacol Immunotoxicol; 2013 Oct; 35(5):622-4. PubMed ID: 23944288
[TBL] [Abstract][Full Text] [Related]
4. Myelin modifications in 8 cases of peripheral neuropathy with Waldenström's macroglobulinemia and anti-MAG activity.
Vital C; Vital A; Deminiere C; Julien J; Lagueny A; Steck AJ
Ultrastruct Pathol; 1997; 21(6):509-16. PubMed ID: 9355233
[TBL] [Abstract][Full Text] [Related]
5. Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.
Stork AC; Notermans NC; Vrancken AF; Cornblath DR; van der Pol WL
J Peripher Nerv Syst; 2013 Jun; 18(2):189-91. PubMed ID: 23781968
[No Abstract] [Full Text] [Related]
6. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy.
Gazzola S; Delmont E; Franques J; Boucraut J; Salort-Campana E; Verschueren A; Sagui E; Hubert AM; Pouget J; Attarian S
J Neurol Sci; 2017 Jun; 377():144-148. PubMed ID: 28477685
[TBL] [Abstract][Full Text] [Related]
9. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
10. Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
Gomez A; Hoffman JE
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):e101-8. PubMed ID: 27245314
[No Abstract] [Full Text] [Related]
11. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
Matà S; Borsini W; Ambrosini S; Toscani L; Barilaro A; Piacentini S; Sorbi S; Lolli F
Eur J Neurol; 2011 Aug; 18(8):1067-73. PubMed ID: 21261794
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
13. IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.
Campagnolo M; Zambello R; Nobile-Orazio E; Benedetti L; Marfia GA; Riva N; Castellani F; Bianco M; Salvalaggio A; Garnero M; Ruiz M; Mataluni G; Fazio R; Ermani M; Briani C
J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1094-1097. PubMed ID: 28501820
[No Abstract] [Full Text] [Related]
14. Worsening after rituximab treatment in anti-mag neuropathy.
Broglio L; Lauria G
Muscle Nerve; 2005 Sep; 32(3):378-9. PubMed ID: 15986418
[No Abstract] [Full Text] [Related]
15. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effects of rituximab in a case of anti-myelin antibody-associated neuropathy].
Shimoyama T; Yaguchi H; Sengoku R; Matsuno H; Mitsumura H; Kono Y; Mochio S
Rinsho Shinkeigaku; 2011 May; 51(5):345-9. PubMed ID: 21706832
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.
Kawagashira Y; Koike H; Takahashi M; Ohyama K; Iijima M; Katsuno M; Niwa JI; Doyu M; Sobue G
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1303-1312. PubMed ID: 32856086
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide-responsive anti-myelin-associated glycoprotein neuropathy.
Stino AM; Efebera Y
Muscle Nerve; 2017 Oct; 56(4):E31-E32. PubMed ID: 28561932
[No Abstract] [Full Text] [Related]
20. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]